SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Genetron Holdings Limited (GTH) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 46/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GTH
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.57
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-9.53
Book Value / Share$0.00
Revenue / Share$7.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-6.22 |
$101.03M |
$-420.64M |
-416.3% |
| 2018 |
$-6.73 |
$225.18M |
$-464.99M |
-206.5% |
| 2019 |
$-4.65 |
$323.43M |
$-321.49M |
-99.4% |
| 2020 |
$-3.29 |
$424.49M |
$-198.11M |
-46.7% |
| 2021 |
$-4.76 |
$531.95M |
$-438.4M |
-82.4% |
| 2022 |
$-9.53 |
$650.71M |
$-883.89M |
-135.8% |
